N-Nitroso Ritonavir Intermediate D6
( CAT No. CS-O-52796 )

N-Nitroso Ritonavir Intermediate D6 is a stable isotope labeled compound of Ritonavir.

Ritonavir was the first truly potent protease inhibitor to enter clinical practice, laying the groundwork for pivotal studies. These investigations unveiled the remarkably high daily production rates of HIV-1.

  • Stable Isotopes
  • Impurities
  • Intermediates
  • API Standards

Ritonavir: Maximizing Antiretroviral Efficacy

Potent CYP3A4 Inhibition: A key mechanism behind ritonavir's ability to boost the effectiveness of other antiretroviral agents.

Pharmacoenhancing Power: Elevates bioavailability of co-administered protease inhibitors, optimizing treatment outcomes.

Dose Optimization: Allows for reduced dosage of protease inhibitors when used in combination with ritonavir, enhancing patient tolerance.